Danaher Corporation is a diversified global science and technology innovator with a significant footprint in the healthcare and life sciences sectors. The company operates through three primary business segments: Biotechnology, Life Sciences, and Diagnostics. The Biotechnology segment provides technologies, consumables, and services that accelerate the development and manufacture of therapeutics, including monoclonal antibodies and gene therapies. The Life Sciences segment offers analytical instruments, microscopes, and genomics consumables used by researchers to study disease and develop new drugs. The Diagnostics segment supplies clinical instruments and software to hospitals and reference laboratories for disease diagnosis and treatment decisions. Danaher's competitive position is strengthened by its recurring revenue model, driven by the sale of consumables and services tied to its installed base of instruments, and its disciplined acquisition strategy integrated through the Danaher Business System.
